SEOUL, South Korea, Jan. 21, 2025 /PRNewswire/ -- Hugel Inc., a leading global medical aesthetics company chaired by Suk Cha, said on Wednesday it received approval for its botulinum toxin Botulax ...

Hugel Inc., a leading global medical aesthetics company publicly traded in South Korea, has delivered record consolidated results for the first quarter. On Thursday, the company reported net sales of ...

Hugel, South Korea's botulinum toxin products maker, has been recognized by the government for its recent accomplishments in exports, the company said Friday. According to Hugel, the company has been ...

- Revenue of KRW81.6bn, Operating profit of KRW28bn...28% YoY growth - Botulinum toxin and HA filler sales growth in both domestic and overseas market... Strong performance in Europe and Asia Pacific ...

For Hugel, the French DJ and producer, music has always been a form of mapmaking - connecting the rhythms of his Marseille childhood with global dance floors. He’s spun his way from secret boarding ...

At long last Marseille’s finest – and Cr2 label mates – Matt Sassari and HUGEL have finally come together to unleash one of the year’s hottest records ‘It Feels So Good’ – out now via Cr2 Records.

Hugel, a South Korean botulinum toxin company, announced Monday that the US Food and Drug Administration has granted marketing approval for the company’s botulinum toxin, Letybo. Hugel expects to ...

Hugel, Korea's largest botulinum toxin maker, wants 80 percent of its sales to come from overseas by 2025. It was one of the goals Sohn Ji-hoon, CEO of Hugel, revealed during an online celebration ...

SEOUL, South Korea, March 31, 2026 /PRNewswire/ -- Hugel Inc., a leading global medical aesthetics company publicly traded in South Korea, has accelerated its growth strategy by adding an ...